Gastrin-releasing peptide receptor antagonist [Ga-68]RM2 PET/CT for staging of pre-treated, metastasized breast cancer

MLA

K. Michalski, et al. “Gastrin-Releasing Peptide Receptor Antagonist [Ga-68]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer.” 60. Jahrestagung Der Deutschen Gesellschaft Für Nuklearmedizin, Apr. 2022. EBSCOhost, https://doi.org/10.1055/s-0042-1746071.

APA

K. Michalski, L. Kemna, J. Asberger, A.L. Grosu, T. Sprave, P.T. Meyer, & J. Ruf. (2022). Gastrin-releasing peptide receptor antagonist [Ga-68]RM2 PET/CT for staging of pre-treated, metastasized breast cancer. 60. Jahrestagung Der Deutschen Gesellschaft Für Nuklearmedizin. https://doi.org/10.1055/s-0042-1746071

Chicago

K. Michalski, L. Kemna, J. Asberger, A.L. Grosu, T. Sprave, P.T. Meyer, and J. Ruf. 2022. “Gastrin-Releasing Peptide Receptor Antagonist [Ga-68]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer.” 60. Jahrestagung Der Deutschen Gesellschaft Für Nuklearmedizin, April. doi:10.1055/s-0042-1746071.